ALGERT GLOBAL LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALGERT GLOBAL LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$474
-80.9%
56,660
-43.3%
0.02%
-79.6%
Q2 2023$2,482
+351.3%
99,931
+173.2%
0.11%
+315.4%
Q1 2023$550
-75.1%
36,580
-80.4%
0.03%
-78.9%
Q4 2022$2,213
-99.7%
187,029
+72.7%
0.12%
+215.4%
Q3 2022$641,000
+51.2%
108,309
+8.7%
0.04%
+21.9%
Q2 2022$424,000
-33.2%
99,670
+716.4%
0.03%
-82.3%
Q4 2020$635,00012,2080.18%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders